--

Dr Toby Eyre is a consultant haematologist at Oxford University Hospitals NHS Foundation Trust, specialising in the management of lymphoid malignancies. He is considered a national expert in the management of patients with lymphoma and patients with chronic lymphocytic leukaemia.

Dr. Eyre is active in the field of research and has completed an MD Doctorate Thesis in early phase trials and biomarker studies in aggressive lymphoid disease in 2017; he continues to have an ongoing interest in clinical trials. He completed his haematology training in the Oxford deanery between 2010 and 2017.

Toby is an investigator on a number of national UK lymphoma and chronic lymphocytic leukaemia trials and has published nearly 70 peer-review articles on areas of lymphoma and CLL and has presented regularly at national and international conferences. He is also a core member of the low grade lymphoma and elderly high grade lymphoma NCRI clinical studies group and a member of the BSCH guideline writing group for follicular lymphoma and post-transplantation lymphoproliferative disorders.

In addition to his practice and research, Dr. Eyre also has a strong interest in teaching and training and has completed a post-graduate Diploma in Medical Education.

Diseases, Medical Tests and Treatments

• Immunotherapy
• Chemotherapy
• Lymphoma
• CLL
• Chronic Lymphocytic Leukaemia
• Haemato-oncology
• lymphoid malignancies
• Hodgkins Lymphoma
• Non-Hodgkins Lymphoma
• Clinical trials